Annals of Rehabilitation Medicine (ARM) is the official journal of the Korean Academy of Rehabilitation Medicine. It is an international, peer-reviewed open access journal, which aims to be a global leader in sharing up-to-date knowledge dedicated to the advancement of care and enhancing the function and quality of life of persons with various disabilities and chronic illnesses. As the official journal of one of the largest societies of rehabilitation medicine in Asia and Oceania, more than 3,500 physiatrists regularly receive this journal's table of contents via email, and the number is continually increasing. This journal is endorsed by the International Society of Physical and Rehabilitation Medicine (ISPRM) and the Asia-Oceanian Society of Physical and Rehabilitation Medicine (AOSPRM). International members comprise approximately half the editorial board, conducting peer-reviews of submitted manuscripts or acting as handling editors by assigning peer-review tasks to other reviewers.
The journal encompasses all aspects of physical medicine and rehabilitation, including basic, translational, clinical, and policy research, as well as rehabilitation education. Research areas covered by this journal include rehabilitation for brain disorders, spinal cord injuries, neuromuscular diseases, and dysphagia; cancer, cardiopulmonary, geriatric, pain & musculoskeletal, and pediatric rehabilitation; electrodiagnosis, orthosis & prosthesis, physical therapy, and sports medicine; and other emerging fields in rehabilitation medicine.
Manuscripts include original articles, review articles, brief reports, case reports, images in this issue, and letters to the editor.
All manuscripts must be written in clearly understandable English. Authors whose first language is not English are requested to have their manuscripts checked for grammatical and linguistic correctness before submission. Correct medical terminology should be used, and jargon should be avoided. Use of abbreviations should be minimized and restricted to those that are generally recognized. When using an abbreviated word, it should be spelled out in full on first usage in the manuscript followed by the abbreviation in parentheses. Numbers should be written in Arabic numerals, but must be spelled out when placed in the beginning of a sentence. Measurements should be reported using the metric system, and hematologic and biochemical markers should be reported in International System (SI) of Units. All units must be preceded by one space except percentage (%), temperature (°C), and degree (°).
All submitted manuscripts should be original and should not be considered by other scientific journals for publication at the same time. No part of the accepted manuscript should be duplicated in any other scientific journal without the permission of the editorial board. If plagiarism or duplicate publication related to the papers of this journal is detected, the manuscripts may be rejected, the authors will be announced in the journal, and their institutes will be informed. There will also be penalties for the authors.
ARM follows the recommendations by International Committee of Medical Journal Editors (ICMJE,http://www.icmje.org/) and and the Korean Association of Medical Journal Editors (KAMJE, https://www.kamje.or.kr/en/main_en). Authorship is credited to those who have direct involvement in the study and have made significant contributions to (a) substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (b) drafting the work or revising it critically for important intellectual content; AND (c) final approval of the version to be published; AND (d) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved as recommended by ICMJE. The primary investigator is designated the first author of the study, unless contested by the other authors. The corresponding author is directly responsible for communication and revision of the submitted manuscript. Authors are required to include a statement of responsibility in the manuscript that specifies the contribution of every author at the end of the manuscript, in a section entitled “Author contribution”. All persons who have made substantial contribution, but who are not eligible as authors should be named in the acknowledgments. In the case of change of authorship, a written explanation must be submitted. Change in either the first author or the corresponding author requires approval by the editorial board, and any changes in the other authors require approval by the editor-in-chief.
The corresponding author of an article is asked to inform the editor of the authors’ potential conflicts of interest possibly influencing their interpretation of data. A potential conflict of interest must be disclosed during the online submission process on the appropriate web page. Such conflicts may be financial support or private connections to pharmaceutical companies, political pressure from interest groups, or academic problems based on the “ICMJE Uniform Disclosure Form for Potential Conflicts of Interest” (http://www.icmje.org/coi_disclosure.pdf). The editor will decide whether the information on the conflict should be included in the published paper. Before publishing such information, the editor will consult with the corresponding author. In particular, all sources of funding for a study should be explicitly stated.
Clinical trial defined as “any research project that prospectively assigns human subjects to intervention and comparison groups to study the cause-and-effect relationship between a medical intervention and a health outcome” is recommended to be registered to the primary registry to be prior publication. ARM recommend, as a condition of consideration for publication, registration in a public trials registry. ARM accepts the registration in any of the primary registries that participate in the WHO International Clinical Trials Portal (http://www.who.int/ictrp/en/), NIH ClinicalTrials. gov (http://www.clinicaltrials.gov/), ISRCTN Resister (www.isrctn.org), ANZCTR (https://www.anzctr.org.au/), EudraCT Database (https://eudract.ema.europa.eu/), Clinical Trials Information System (https://euclinicaltrials.eu/), University Hospital Medical Information Network (www.umin.ac.jp/ctr/index/htm), EU Clinical Trials Register (https://www.clinicaltrialsregister.eu/) or The Clinical Research Information Service (http://cris.nih.go.kr/). The clinical trial registration number will be published at the end of the abstract.
When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (COPE, https://publicationethics.org/guidance/Flowcharts). The discussion and decision on the suspected cases are carried out by the Editorial Board.
Cases that require editorial expressions of concern or retraction shall follow the COPE flowcharts available from: https://publicationethics.org/guidance/Flowcharts. If correction needs, it will follow the ICMJE Recommendation for Corrections, Retractions, Republications and Version Control available from:http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/corrections-and-version-control.html.
Authorship assignment to AI is prohibited. ARM discourages the use of generative AI tools for the purpose of creating any types of content (including text, tables, and figures) for scientific manuscripts. If such tools are used, the authors must report their use transparently. In addition, authors who employ generative AI tools are solely responsible for all content produced and submitted. However, the use of AI tools to enhance the linguistic quality of a submission is considered acceptable and does not require specific disclosure.
Annals of Rehabilitation Medicine is an open access journal. To publish in Annals of Rehabilitation Medicine, authors are asked to pay an article processing charge(APC) on acceptance of their research paper. The APC for all published papers is as follows, plus VAT or local taxes where applicable. The currency KRW will be applied to the submissions from South Korea.
†Note: As categorized by the World Bank, low-income countries will be eligible for a 20% discount on the updated APCs for original articles/brief reports/review articles/case reports. To find out if your country qualifies, please refer to the World Bank’s classification available at https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html.
(This updated article processing charge is applied to all submissions as of Oct 1, 2023.)
Conformity of the submitted manuscript to the submission instructions is examined upon submission. The Editorial Board may reject the manuscript or request the author to resubmit in the following cases: 1)Topic clearly out of scope / insufficient perceptual content 2) Work clearly does not meet sufficient standards of novelty or quality 3) Manuscript incomplete or incorrectly formatted 4) Suspected plagiarism in the manuscript.
Submitted manuscripts will be reviewed by two or more peer reviewers selected from the board’s database of expert reviewers. In addition, if deemed necessary, a review of statistics may be requested. Following review, the editorial board will decide whether the manuscript will be 1) accepted for publication, 2) subject to minor revision, 3) subject to major revision, or 4) rejected for publication. For manuscripts which are either subject to minor revision or subject to major revision, the corresponding author must resubmit the revised manuscript online. The revised manuscript should clearly indicate all changes by highlighting the modified text or by using a different color for the altered sections. In addition, the corresponding author must reply to both reviewers’ comments point by point, and explain in detail what changes were made in the manuscript. When considered necessary, the editorial board may make changes to the structure and phrases of the manuscript without compromising the integrity of the original paper. After completion of the peer review process, the editorial board will determine acceptance for publication and notify the corresponding author by e-mail. Manuscripts which do not comply with the present guidelines will be notified for correction or withheld from publication. When a manuscript is not resubmitted within 2 months of notification, it will be considered that the authors have withdrawn the manuscript from submission. Manuscripts accepted for publication are generally published in order of submission, depending on the category of the manuscript and the date of acceptance for publication.
Original papers should be structured in the following order: Abstract, Introduction, Methods, Results, Discussion, Conflict of interests, Funding information, Author contribution, Acknowledgments (when applicable), References, Tables, Figure legends, and Figures. Maximum word count is limited to 5,000 words.
The abstract should contain no more than 250 words and 5 keywords. The text is structured in the order of Introduction, Main text, Conclusion, Conflict of interests, Funding information, Author contribution, Acknowledgments (when applicable), References, Tables, Figure legends, and Figures.
General guidelines are the same as for the original article. The manuscript is structured in the order of Abstract, Main text, Conflict of interests, Funding information, Author contribution, Acknowledgments (when applicable), References, Tables, Figure legends, and Figures. A structured abstract is required and limited to 150 words, with no more than 3 keywords attached. Manuscripts should be limited to 1,500 words of text including references and figure legends (not including abstract, tables, and figures), and no more than 10 references. The total number of figures and/or tables is limited to 3.
General guidelines and order of manuscript preparation are the same as for the original article. Case reports are considered for publication only if they report rare conditions, atypical symptoms and signs, novel diagnostic or therapeutic approaches, or describe atypical findings for populations residing in Asia and the Pacific Rim. The editorial board will determine whether the case report fulfills the above criteria for acceptance of publication. The manuscript is structured in the order of Abstract, Introduction, Case report, Discussion, Conflict of interests, Funding information, Author contribution, Acknowledgments (when applicable), References, Tables, Figure legends, and Figures. The abstract should be nonstructured and limited to 150 words, with no more than 3 keywords attached. The introduction should briefly state the background and significance of the case. The actual case report should describe the clinical presentation and the diagnostic and therapeutic measures taken. The discussion should focus on the uniqueness of the case and should not contain extensive review of the disease or disorder. The combined number of tables and figures is limited to 5, and the number of references is limited to 10. Maximum word count is limited to 1,500 words including references and figure legends.
All images should be accompanied by a short description of the image and a brief and concise clinical review of the specific patient or clinical issue of no more than 500 words (excluding references) with references limited to 5. Image files must be of resolutions higher than 300 dpi for photographs, and 900 dpi for line art, waveforms, and graphs, in JPEG, GIF, TIFF, or Microsoft PowerPoint format. Images should make up a single figure, although they may contain more than one frame. The manuscript does not have an abstract.
Letters should not have an abstract, tables, figures, and data supplements. Letters must be limited to roughly 500 words of text and no more than 5 references, 1 of which should be to the recent ARM article. Letters may have no more than 3 authors.
For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies, and non-randomized studies, it is recommended that the authors follow the reporting guidelines listed in the following table.
Initiative | Type of study | Source |
---|---|---|
CONSORT | Randomized controlled trials |
http://www.consort-statement.org |
STARD | Studies of diagnostic accuracy |
http://www.stard-statement.org |
PRISMA | Preferred reporting items of systematic reviews and metaanalyses |
http://www.prisma-statement.org |
STROBE | Observational studies in epidemiology |
http://www.strobe-statement.org |
MOOSE | Meta-analyses of observationa studies in epidemiology | http://www.consort-Statement.org/resources/downloads/other-instruments/moose-statement-2000pdf |
When accepted for publication, the authors’ institutional affiliations should be inserted into the text of the final revised manuscript and uploaded to the online submission system. Files containing figures should be of the highest resolution (at least 300 dpi for color figures, and 900 dpi for line art and graphs) should be also be uploaded in JPEG, GIF, or TIFF format, and must be named according to the figure number (e.g., Fig. 1.jpg).
Galley proofs will be sent to the corresponding author for final corrections. Corrections should be kept to a minimum, must be returned within 2 days, otherwise publication may be delayed. Any fault found after the publication is the responsibility of the authors. We urge our contributors to proofread their accepted manuscripts very carefully. After the publication, if there are critical errors, they should be corrected as Corrigendum or Erratum.
The editorial board retains the right to request minor stylistic and major alterations that might influence the scientific content of the paper. The final manuscript will be published following final approval by the editor-in-chief.